Sydney biotech raises $5 million with Covid vaccine plan
Biotech startup EnGeneIC, has raised $5 million on the VentureCrowd platform in a pre-IPO round, ahead of plans for a NASDAQ listing in Q2 2022. News of positive results for Covid-19 nanocellular vaccine pre-clinical animal studies, saw that figure jump five-fold. The startup has develop proprietary nanocell technology, which they’ve called EDV, which is predominantly… Read more »